Maria Gracia-Hernandez

Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells

Tessa Knox, Eva Sahakian, Debarati Banik et al. · Scientific Reports · 2019 · 158 citations · Full text

HDAC6 Plays a Noncanonical Role in the Regulation of Antitumor Immune Responses, Dissemination, and Invasiveness of Breast Cancer

Debarati Banik, Satish Noonepalle, Melissa Hadley et al. · Cancer Research · 2020 · 62 citations · Full text

Hdac Inhibitors, Noncanonical Role, Breast Oncology +16

Targeting Macrophages as a Therapeutic Option in Coronavirus Disease 2019

Maria Gracia-Hernandez, Eduardo M. Sotomayor, Alejandro Villagra · Frontiers in Pharmacology · 2020 · 53 citations · Full text

Viral Pathogenesis, Immunology, Pathology +17

Targeting HDAC6 improves anti-CD47 immunotherapy

Maria Gracia-Hernandez, Ashutosh S. Yende, Nithya Gajendran et al. · Journal of Experimental & Clinical Cancer Research · 2024 · 21 citations · Full text

Cell therapy using ex vivo reprogrammed macrophages enhances antitumor immune responses in melanoma

Satish Noonepalle, Maria Gracia-Hernandez, Nima Aghdam et al. · Journal of Experimental & Clinical Cancer Research · 2024 · 18 citations · Full text